CGC
Price
$1.49
Change
-$0.04 (-2.61%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
784.64M
56 days until earnings call
MEDIF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Capitalization
19.13M
Interact to see
Advertisement

CGC vs MEDIF

Header iconCGC vs MEDIF Comparison
Open Charts CGC vs MEDIFBanner chart's image
Canopy Growth
Price$1.49
Change-$0.04 (-2.61%)
Volume$117.73K
Capitalization784.64M
Medipharm Labs
Price$0.07
Change-$0.00 (-0.00%)
Volume$369.49K
Capitalization19.13M
CGC vs MEDIF Comparison Chart
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. MEDIF commentary
Jun 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and MEDIF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 13, 2025
Stock price -- (CGC: $1.53 vs. MEDIF: $0.06)
Brand notoriety: CGC: Notable vs. MEDIF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 51% vs. MEDIF: 248%
Market capitalization -- CGC: $784.64M vs. MEDIF: $19.13M
CGC [@Pharmaceuticals: Other] is valued at $784.64M. MEDIF’s [@Pharmaceuticals: Other] market capitalization is $19.13M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileMEDIF’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • MEDIF’s FA Score: 0 green, 5 red.
According to our system of comparison, MEDIF is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while MEDIF’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 5 bearish.
  • MEDIF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CGC and MEDIF are a bad buy in the short-term.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а +11.68% price change this week, while MEDIF (@Pharmaceuticals: Other) price change was +17.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.07%. For the same industry, the average monthly price growth was +14.57%, and the average quarterly price growth was +67.09%.

Reported Earning Dates

CGC is expected to report earnings on Aug 08, 2025.

MEDIF is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($785M) has a higher market cap than MEDIF($19.1M). MEDIF YTD gains are higher at: 57.385 vs. CGC (-44.161). MEDIF has higher annual earnings (EBITDA): -41.42M vs. CGC (-1.02B). CGC has more cash in the bank: 186M vs. MEDIF (20.2M). MEDIF has less debt than CGC: MEDIF (218K) vs CGC (693M). CGC has higher revenues than MEDIF: CGC (362M) vs MEDIF (22.2M).
CGCMEDIFCGC / MEDIF
Capitalization785M19.1M4,110%
EBITDA-1.02B-41.42M2,468%
Gain YTD-44.16157.385-77%
P/E RatioN/AN/A-
Revenue362M22.2M1,631%
Total Cash186M20.2M921%
Total Debt693M218K317,890%
FUNDAMENTALS RATINGS
CGC vs MEDIF: Fundamental Ratings
CGC
MEDIF
OUTLOOK RATING
1..100
1020
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
6049
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEDIF's Valuation (89) in the null industry is in the same range as CGC (90) in the Agricultural Commodities Or Milling industry. This means that MEDIF’s stock grew similarly to CGC’s over the last 12 months.

MEDIF's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that MEDIF’s stock grew similarly to CGC’s over the last 12 months.

MEDIF's SMR Rating (92) in the null industry is in the same range as CGC (95) in the Agricultural Commodities Or Milling industry. This means that MEDIF’s stock grew similarly to CGC’s over the last 12 months.

MEDIF's Price Growth Rating (49) in the null industry is in the same range as CGC (60) in the Agricultural Commodities Or Milling industry. This means that MEDIF’s stock grew similarly to CGC’s over the last 12 months.

MEDIF's P/E Growth Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that MEDIF’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCMEDIF
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLEIX60.590.06
+0.10%
Value Line Small Cap Opportunities Instl
SGACX20.78N/A
N/A
Virtus SGA Global Growth C
CDOZX39.18N/A
N/A
Columbia Dividend Opportunity Inst
FLCOX18.85N/A
N/A
Fidelity Large Cap Value Index
WCMNX12.07N/A
N/A
WCM Small Cap Growth Investor

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-2.55%
SNDL - CGC
77%
Closely correlated
+1.50%
ACB - CGC
67%
Closely correlated
+0.83%
TLRY - CGC
63%
Loosely correlated
-2.23%
OGI - CGC
58%
Loosely correlated
N/A
CRON - CGC
58%
Loosely correlated
+1.53%
More

MEDIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDIF has been loosely correlated with CGC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDIF jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDIF
1D Price
Change %
MEDIF100%
+10.17%
CGC - MEDIF
36%
Loosely correlated
-2.55%
TLRY - MEDIF
28%
Poorly correlated
-2.23%
ACB - MEDIF
24%
Poorly correlated
+0.83%
AAWH - MEDIF
24%
Poorly correlated
+9.93%
GLASF - MEDIF
24%
Poorly correlated
-1.88%
More